BlueRock Therapeutics and bit.bio’s Collaboration and Option Agreement

Pietro Martinoia
Tagged:

Goodwin advised bit.bio on the agreement.BlueRock Therapeutics LP, a wholly owned, independently operated subsidiary of Bayer AG, and bit.bio announced a collaboration and option agreement for the…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now